Radiosurgery Dose Selection Based on Cellular Imaging
- Event: 7th International Conference of the Novalis Circle 2017
- Topic: Brain Metastasis
- Year: 2017
Douglas Kondziolka, MD, of NYU Langone Medical Center describes radiosurgery dose selection based on cellular imaging and how radiosurgery may move forward into the future. He begins by discussing how choosing the dose for radiosurgery is dependent on crude metrics like tumor type, location, volume and other therapies, despite being a high precision treatment. In a 2 year study of 43 select patients, Dr. Kondziolka and team attempted to introduce a quantitative MRI approach to SRS treatment planning and post treatment follow-up. He goes into detail about the patient group and study itself by using case examples and discussing the specific approaches.
About the speaker
Douglas Kondziolka, MD, MSc
NYU Langone Medical Center, New York City, USA
Professor of Neurosurgery and Radiation Oncology at NYU Langone Medical Center
- Dr. Douglas Kondziolka received his medical degree from the University of Toronto and graduated from the Toronto neurosurgery residency program in 1991.
- From 1989 to 1991 at the University of Pittsburgh, he completed a master of science program in the Department of Behavioral Neuroscience and a fellowship in stereotactic surgery and radiosurgery. His thesis focused on brain radiobiology.
He joined the faculty of the Department of Neurological Surgery at the University of Pittsburgh in January 1992 and later was named Chief of Stereotactic and Functional Neurosurgery. His laboratory and clinical research in stereotactic radiosurgery spans the breadth of indications including benign and malignant tumors, vascular malformations and functional disorders.
In November 2012, Dr. Kondziolka joined the neurosurgery faculty at New York University as Professor and Vice-Chair for Clinical Research. He launched the first global registry platform for neurosurgery that focused initially on the broad array of radiosurgical indications. A current research focus is on metabolic and vascular effects of brain tumor radiosurgery using novel neuroimaging techniques.
Dr. Kondziolka has published 550 articles in refereed journals, 260 book chapters and/or invited publications, and has edited 8 books. He has completed four randomized controlled trials.
- He is a two-time recipient of the Stephen Mahaley Award for brain tumor clinical research from the Joint Section on Tumors of the AANS/CNS.
- He received the Lars Leksell Award from the World Federation of Neurosurgical Societies.
- In 2004, he was honored as the Penfield Lecturer of the Canadian Neurosurgical Society.
- In 2006 he received the Robert Florin Award of the American Association of Neurological Surgeons for socio-economic research, and in 2007, the AANS Integra Foundation Award.
- In 2007 he received the Jacob Fabrikant Award from the International Stereotactic Radiosurgery Society.
- In 2014 he received the Bernard Sanberg Award for significant research contributions from the American Society for Neural Therapy and Repair.
He is a past President of the American Society for Stereotactic and Functional Neurosurgery, and Past-President of the International Stereotactic Radiosurgery Society. In 2006-2007, he served as President of the Congress of Neurological Surgeons. He served as neurosurgeon for the Pittsburgh Penguins of the National Hockey League from 2002-2012. He served as co-chair of the editorial board of the Journal of Neurosurgery (2008-2013) and is now Associate Editor. He serves on the board of the Neuropoint Alliance. In 2014 he became a Director of the American Board of Neurological Surgery and is current Chair of the Oral Examination Committee. He has been a visiting professor at the top institutions in the United States and Canada, and has lectured extensively across the world.
Surgery for Brain Metastasis: Does It Still Have A Role?
The Non-Inferiority of Radiosurgery Alone as Initial Therapy for Patients with more than Five Brain Metastases
Clinical Experience Utilizing the Elements Multiple Brain Mets SRS and TRAMS
Neo-Adjuvant SRS Versus En Bloc Resection
The Role of 6D IGRT in Positioning and Monitoring for Single Isocenter Planning
Clinical Evaluation of Post-Radiotherapy Neurocognitive Function and Tools for its Assessment
How Research is Breaking the Rules of Brain Metastasis Patient Care
How Radiosurgery Transformed Neurosurgery and the Changes that Lie Ahead
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.WATCH Video
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.Watch video No Thanks
Already Novalis Circle Member?Member Login